


| Artiva launches with $78M to develop Korean biotech’s NK cell programs outside Asia |
|
A U.S. investor syndicate and management team have set up Artiva, bringing to San Diego allogeneic natural killer cell technology from South Korean company GC LabCell -- including one program due to enter the clinic this year. Artiva Biotherapeutics Inc.
Posted: 2020-06-27 06:03:00
|
If you are a broadcaster or Christian program producer you can schedule a 15 min FREE consultation with an EGR specialist to help you evaluate all possible Int'l broadcasting options.
We will call you back at a number and time of your convenience, and will gladly answer any question that you may have on how to broadcast your Christian message worldwide.